NSE filing, NSE: AARVI. Summary written from the filing by ALFA Finder's alert engine.
Aarvi Encon Ltd: key numbers
- Share price
- ₹132.22
- Market cap
- ₹196.2 Cr
- Revenue (annual)
- ₹649.9 Cr
- Net profit (annual)
- ₹17.62 Cr
- P/E (TTM)
- 10.1×Sector 34.1×
- Promoter holding
- 73.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarvi Encon Ltd
All →Aarvi Encon Board Meeting Date
Aarvi Encon will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for September 2026. Trading window remains closed until 6 November.
Aarvi Encon Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the LODR Regulations.
Aarvi Encon Business Update
Aarvi Encon Limited has been recognized in Dun & Bradstreet's "Leading SMEs of India 2026" publication. The company was featured among 13,610 enterprises in the services category.
Aarvi Encon Investor Presentation: Key Takeaways
Aarvi Encon reported Q1 FY27 revenue of INR 1,727 Mn with a 2.61% EBITDA margin. The company maintains its position as India's leading technical manpower provider with over 8,000 professionals deployed.
Aarvi Encon Bags ₹174.7 Cr Order
Aarvi Encon Limited secured a Rs. 174.73 Crore manpower supply contract from Certification Engineers International Limited. The project spans three years starting September 2026.
- Value
- ₹174.7 Cr
- Execution
- 01-09-2026 to 31-08-2029
Aarvi Encon Management Change
Aarvi Encon Limited reported the unfortunate demise of Mr. Reyaz Khan, General Manager – Kolkata Branch. He was a member of the Senior Management Personnel since 2008.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date